Allergan Inc (Irvine, Calif) announced Tuesday that the FDA has approved label extensions for its Juvéderm™ family of dermal filler products. New clinical data demonstrate that the effects of Juvéderm Ultra and Juvéderm Ultra Plus hyaluronic acid (HA) products may last up to 1 year.

An Allergan study involving follow-up data from 225 patients determined the product’s new-found persistence.

According to Robert Grant, the president of Allergan Medical, a division of Allergan, the company provides the only HA dermal filler product currently approved in the United States to “provide smooth, natural looking results lasting up to 1 year with a single treatment.”

[June 26; Business Wire]